Comprehensive Mitochondrial Disorders Gene Analysis Panel, NGS (Genomic Unity®)
Succinate Dehydrogenase (SDHA, SDHB, SDHC and SDHD) Gene Mutation Analysis
Cytochrome P450 2B6 (CYP2B6) Genotyping
Calprotectin, Fecal
Thermoactinomyces vulgaris, Antibody, IgG
Biopsy, Prostate
Cytochrome P450 2E1 (CYP2E1) Genotyping
Metanephrines, Plasma
Clostridium difficile (C. Diff), Culture
Temazepam, Urine
LDS
Sign up
Log in
LDS
/
Medical Tests
/
EarlyTect® Bladder Cancer Detection Test (PENK Gene Methylation Assay)
All
Diseases
Overview
Clinical Utility
Interpretation
Reference Ranges
Methodology
Specimen Collection
Additional Testing
Turnaround Time
CPT
ICD10
Additional ICD10
References
All
Diseases
Overview
Clinical Utility
Interpretation
Reference Ranges
Methodology
Specimen Collection
Additional Testing
Turnaround Time
CPT
ICD10
Additional ICD10
References
EarlyTect® Bladder Cancer Detection Test (PENK Gene Methylation Assay)
Medical Test
Interpretation
Access to
EarlyTect® Bladder Cancer Detection Test (PENK Gene Methylation Assay)
is restricted.
Sign up now